1725 related articles for article (PubMed ID: 15765624)
41. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
Chabre O
Ann Endocrinol (Paris); 2018 Jun; 79(3):138-145. PubMed ID: 29716734
[TBL] [Abstract][Full Text] [Related]
42. [Endogenous Cushing's syndrome: clinical and laboratorial features in 73 cases].
Vilar L; Naves LA; Freitas Mda C; Moura E; Canadas V; Leal E; Teixeira L; Gusmão A; Santos V; Campos R; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Lyra R; Azevedo MF; Casulari LA
Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):566-74. PubMed ID: 17684617
[TBL] [Abstract][Full Text] [Related]
43. [Cushing's disease caused by adrenocortical nodular hyperplasia--diagnosis and surgical treatment].
Miura M; Matsukado Y; Kodama T; Hiramatsu R
No Shinkei Geka; 1984 May; 12(6):689-96. PubMed ID: 6087181
[TBL] [Abstract][Full Text] [Related]
44. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
[TBL] [Abstract][Full Text] [Related]
45. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
[TBL] [Abstract][Full Text] [Related]
46. Cushing's syndrome due to an ectopic ACTH-secreting pituitary tumour mimicking occult paraneoplastic ectopic ACTH production.
Bethge H; Arlt W; Zimmermann U; Klingelhöffer G; Wittenberg G; Saeger W; Allolio B
Clin Endocrinol (Oxf); 1999 Dec; 51(6):809-14. PubMed ID: 10619988
[TBL] [Abstract][Full Text] [Related]
47. Cushing's Syndrome: important issues in diagnosis and management.
Findling JW; Raff H
J Clin Endocrinol Metab; 2006 Oct; 91(10):3746-53. PubMed ID: 16868050
[TBL] [Abstract][Full Text] [Related]
48. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
[TBL] [Abstract][Full Text] [Related]
49. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
[TBL] [Abstract][Full Text] [Related]
50. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
51. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
[TBL] [Abstract][Full Text] [Related]
52. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
53. The differential diagnosis of Cushing's syndrome.
Newell-Price J; Grossman AB
Ann Endocrinol (Paris); 2001 Apr; 62(2):173-9. PubMed ID: 11353890
[TBL] [Abstract][Full Text] [Related]
54. Exacerbation of Cushing's syndrome during pregnancy: stimulation of a cortisol-secreting adrenocortical adenoma by ACTH originating from the foeto-placental unit.
St-Jean M; MacKenzie-Feder J; Bourdeau I; Lacroix A
Endocrinol Diabetes Metab Case Rep; 2019 Feb; 2019():. PubMed ID: 30738017
[TBL] [Abstract][Full Text] [Related]
55. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH.
Croughs RJ; Zelissen PM; van Vroonhoven TJ; Hofland LJ; N'Diaye N; Lacroix A; de Herder WW
Clin Endocrinol (Oxf); 2000 Feb; 52(2):235-40. PubMed ID: 10671952
[TBL] [Abstract][Full Text] [Related]
56. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
[TBL] [Abstract][Full Text] [Related]
57. Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: a study of 210 cases.
Kuhn JM; Proeschel MF; Seurin DJ; Bertagna XY; Luton JP; Girard FL
Am J Med; 1989 Jun; 86(6 Pt 1):678-84. PubMed ID: 2543219
[TBL] [Abstract][Full Text] [Related]
58. Ectopic production of ACTH and corticotropin-releasing hormone (CRH).
Müller OA; von Werder K
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):403-8. PubMed ID: 1327073
[TBL] [Abstract][Full Text] [Related]
59. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
60. Recent challenges in the diagnosis of Cushing's syndrome.
Pecori Giraldi F
Horm Res; 2009 Jan; 71 Suppl 1():123-7. PubMed ID: 19153521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
